TMDX - TransMedics Group, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5350.66M
Enterprise Value 3314.85M
Trailing P/E N/A
Forward P/E 1-14.11
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)16.63
Price/Book (mrq)5.65
Enterprise Value/Revenue 314.93
Enterprise Value/EBITDA 6-12.02

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 315.46%
52 Week High 331.54
52 Week Low 315.74
50-Day Moving Average 318.72
200-Day Moving Average 319.74

Share Statistics

Avg Vol (3 month) 3195.32k
Avg Vol (10 day) 3142.26k
Shares Outstanding 521.16M
Float 12.01M
% Held by Insiders 128.65%
% Held by Institutions 176.63%
Shares Short (Jan 14, 2020) 41.58M
Short Ratio (Jan 14, 2020) 46.49
Short % of Float (Jan 14, 2020) 421.83%
Short % of Shares Outstanding (Jan 14, 2020) 47.46%
Shares Short (prior month Dec 12, 2019) 41.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 28, 2018
Most Recent Quarter (mrq)Sep 27, 2019

Profitability

Profit Margin -151.75%
Operating Margin (ttm)-129.30%

Management Effectiveness

Return on Assets (ttm)-21.17%
Return on Equity (ttm)-96.88%

Income Statement

Revenue (ttm)21.09M
Revenue Per Share (ttm)1.67
Quarterly Revenue Growth (yoy)78.40%
Gross Profit (ttm)5.73M
EBITDA -26.18M
Net Income Avi to Common (ttm)-32.01M
Diluted EPS (ttm)-2.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)88.27M
Total Cash Per Share (mrq)4.17
Total Debt (mrq)34.02M
Total Debt/Equity (mrq)53.60
Current Ratio (mrq)7.33
Book Value Per Share (mrq)3.00

Cash Flow Statement

Operating Cash Flow (ttm)-31.14M
Levered Free Cash Flow (ttm)-20M